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ABSTRACT: Development of highly sensitive and selective sensing systems of divalent zinc ion (Zn2+) in organisms has been a 
growing interest in the past decades owing to its pivotal role in cellular metabolism, apoptosis and neurotransmission. Herein, 
we report the rational design and synthesis of a Zn2+ fluorescent-based probe by assembling lanthanide-doped upconversion 
nanoparticles (UCNPs) with chromophores. Specifically, upconversion luminescence (UCL) can be effectively quenched by 
the chromophores on the surface of nanoparticles via a fluorescence resonant energy transfer (FRET) process and subsequently 
recovered upon the addition of Zn2+, thus allowing for quantitative monitoring of Zn2+. Importantly, the sensing system 
enables detection of Zn2+ in real biological samples. We demonstrate that this chromophore-UCNP nanosystem is capable of 
implementing an efficient in vitro and in vivo detection of Zn2+ in mouse brain slice with Alzheimer’s disease and zebrafish, 
respectively. 
■ INTRODUCTION 
As the second most abundant d-block metal ion in human 
brain and an active component in enzymes and proteins,1 
Zn2+ plays an important role in life processes including gene 
expression and neurotransmission.2fThe extent of Zn2+ 
deficiency is also associated with physical growth 
retardation and neurological disorder such as cerebral 
ischemia and Alzheimer’s disease (AD).3 Therefore, there is 
an increasing demand for highly sensitive analytical 
methods for the detection of Zn2+. The in vivo temporal and 
spatial detection of Zn2+ is challenging but essential to 
address Zn2+-related issues. Tremendous efforts has been 
devoted to developing sensitive Zn2+-monitoring 
approaches.4 Amongst them, fluorescence spectroscopy is 
particularly useful owing to its high sensitivity, ease of use, 
and ability to facilitate real-time detection.5 Previously 
published fluorescent Zn2+ probes based on organic dyes and 
inorganic nanoparticles are summarized in Table S1. 
Lanthanide-doped upconversion nanoparticles (UCNPs), 
which are capable of converting near infrared (NIR) 
excitation light to short wavelength emissions, have 
emerged as a promising luminescent probe in potential 
applications in sensing and bioimaging owing to their 
intriguing characteristics, such as a large anti-Stokes shift of 
up to several hundred nanometers, non-autofluorescence 
from biosamples, high penetration depth and no 
photobleaching.6 Alternatively, chromophores with specific 
recognition sites are widely used for highly selective sensing 
systems. Therefore, the integration of UCNPs and 
chromophores endows the hybrid system with the 
outstanding recognition properties of chromophores and 
remarkable imaging capacity from UCNPs, thus producing 
highly sensitive and selective sensing system based on 
fluorescence resonance energy transfer (FRET) process 
between them. Till now, a number of UCNPs-based FRET 
systems have been developed to detect various analytes, 
such as DNA,7 O2,8 CN-,9 NH4,10 and Hg2+.11 To the best of 
our knowledge, UCNPs-based selective fluorescence probes 
for Zn2+ detection in real biological samples have yet been 
reported. 
To address this need, we have developed multilayered 
UCNPs modified with polyacrylic acid and compound 1, 
respectively, as probes (abbreviated as 1-PAA-UCNPs 
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shown in Figure 1) for sensitive and rapid monitoring of 
Zn2+ ions. A FRET process with NaYF4:Yb/Tm@NaYF4 
(20/0.2 mol%) as the energy donor and Zn2+-responsive 
compound 1 as the acceptor was constructed. Formation of 
a Zn-1 complex inhibits the FRET, thus enabling the 
detection of Zn2+ in aqueous solution. Importantly, this 
hybrid nanoprobe is also applicable for upconversion 
luminescence (UCL) imaging of Zn2+-rich amyloid brain 
tissues with AD. We further demonstrate its capability to 
detect endogenous Zn2+ in a living animal model of 
zebrafish.  
■ RESULTS AND DISCUSSION 
Design Principle of the UCL Nanosensor for Zn2+. Our 
designed sensing system relies on a FRET process in 1-PAA-
UCNPs for detection of Zn2+ (Figure 1a). In this process, 
NaYF4:Yb/Tm@NaYF4 upconversion nanocrystals with blue 
UCL were used as energy donor. Alternatively, a Zn2+ 
responsive compound 1 assembled on the surface of 
upconversion nanocrystals was chosen as energy acceptor 
because of large overlapping between its absorption band 
with the UCL. In the absence of Zn2+, the UCNPs give rise 
to blue emissions originating from the 1G4→3H6 transition of 
Tm3+ under the excitation of a 980 nm laser. This UCL could 
be quenched by compound 1 with a strong absorbance band 
centered at 475 nm (Figure 1c), which is accompanied by 
the reduction in the I475 nm/I654 nm ratio of UCL. In the 
presence of Zn2+, the coordination of Zn2+ with the 
compound 1 could lead to a significant blue-shift of the 
absorbance of 1-PAA-UCNPs from 475 to 360 nm due to 
the intramolecular charge transfer of compound 1 (Figure 
S1), thereby resulting in energy mismatch between the 
absorption of compound 1 and the blue emission of UCNPs. 
Therefore, the energy transfer (ET) from the UCNPs to 
compound 1 is suppressed, while the UCL signal located at 
475 nm can be recovered. This variation in UCL intensity 
allows us to achieving quantitative monitoring of Zn2+. On a 
separate note, the absorption band of compound 1 shows no 
overlap with the red emission (1G4→3F4 transition) of Tm3+ 
at 654 nm upon the addition of Zn2+, which could be used as 
an inner reference to determine the Zn2+ concentration.  
 
Figure 1. (a) Schematic illustration showing the synthesis of chromophore-assembled UCNPs and their response to Zn2+. (b) Photographs 
showing the solution (left) and corresponding upconversion luminescence (right) of PAA-UCNPs (1 mg/mL), 1-PAA-UCNPs (1 mg/mL) and 
1-PAA-UCNP with Zn2+ (120 μM), respectively. (c) UV-vis spectra of compound 1 measured in the absence (red line, 0.1 mM) and 
presence (dark yellow line, 120 μM) of Zn2+ and UCL spectrum of PAA-UCNPs (blue line). Inserted is the molecular structure of 
compound 1. 
 
Figure 2. (a) TEM images of NaYF4:Yb/Tm(20/0.2 mol%)@NaYF4 
core-shell nanocrystals. (b) The upconversion luminescence spectra 
of the NaYF4:Yb/Tm (20/0.2% mol%) and NaYF4:Yb/Tm(20/0.2% 
mol%)@NaYF4 UCNPs under the 980 nm excitation. (c) X-ray 
powder diffraction pattern of the as-prepared NaYF4:Yb/Tm core 
and NaYF4:Yb/Tm@NaYF4 core-shell nanoparticles, showing that all 
peaks can be well indexed in accordance with pure hexagonal 
NaYF4 (JCPDS card No.15-0334). 
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Synthesis and Characterization of 1-PAA-UCNPs. In the 
present study, in order to obtain effective UCL, pure 
hexagonal-phase core-shell UCNPs with an average 
diameter of ∼16 nm (Figure 2a, 2c, S2, and S3) were 
prepared according to the literature.12 In a typical procedure, 
NaYF4:Yb/Tm (20/0.2 mol%) nanocrystals were firstly 
synthesized as the core and subsequently coated by NaYF4 
shell through the epitaxial growth. The core-shell design 
can minimize surface quenching induced energy loss13 and 
improve the UCL emission intensity by 10 times (Figure 2b). 
To integrate UCNPs and compound 1 together into one 
nanosystem, the oleic acid (OA) ligands on the surface of 
UCNPs were firstly replaced by negatively charged 
hydrophilic PAA.14 It should be noted that the size and 
morphology of nanocrystals did not change during the 
ligand exchange process (Figure S4 and S5). Then the 
positively charged compound 1 was assembled onto the 
UCNPs surface through electrostatic attraction. With 
increasing concentrations of compound 1, the UCL intensity 
of UCNPs remarkably decreased (Figure S6). The absorption 
spectroscopy result revealed that the amount of compound 
1 on the surface of the UCNPs was 0.58×10-4 M, which was 
approximately 7.6 wt% of the 1-PAA-UCNPs (Figure S7). 
To prove the stability of 1-PAA-UCNPs in biological 
environments, the as-prepared nanoprobes were dispersed 
in different media, such as water, PBS (0.1 M, pH = 7.0), 
HEPES (1 M, pH = 7.0), DMEM medium (containing 10% 
FBS) or cell extracts, and kept for 24 hr prior to the 
measurement of UCL (Figure S8). It was found that the UCL 
signals remained essentially constant as compared to the 
non-incubated solution counterparts, clearly suggesting that 
the developed nanoprobe is feasible for applications in 
biological settings.  
Zn2+-Sensing Capabilities of 1-PAA-UCNPs. To examine 
the effect of Zn2+ concentration on the optical properties of 
1-PAA-UCNPs, we added different concentrations of Zn2+ 
into the aqueous solution containing as-prepared 
nanoprobes. As expected, upon addition of Zn2+ to the 
solution of 1-PAA-UCNPs, a significant increase in the UCL 
intensity at 475 nm could be observed owing to the blue 
shift absorption of compound 1 (Figure 3a, 3b and S9). 
Significantly, we surprisingly found that the variation of 
color and UCL has fast response within 5 s. (Figure S10, 
movie in Supporting Information).  
To further investigate the selectivity of 1-PAA-UCNPs 
sensors, we tested a series of solution including various 
biological metal ions, amino acid including cysteine (Cys), 
homocysteine (Hcy), and glutathione (GHS). As shown in 
Figure 3c, only Zn2+ could induce obvious signal change of 
1-PAA-UCNPs. In contrast, other metal ions (e.g. Ca2+, Fe3+, 
Mn2+, Ba2+, Na+, K+) and amino acids did not result in any 
 
Figure 3. (a) Photoluminescence response of 1-PAA-UCNPs 
solutions (1 mg/mL) as a function of Zn2+ concentration (0−0.09 
mM) in an aqueous solution (normalized to 654 nm emission). (b) 
Plot of luminescence intensity at UCL475 nm/UCL654 nm against the 
Zn2+ concentration. (c) UCL spectra of 1-PAA-UCNPs solutions (1 
mg/mL) in the presence of different cations (0.1 mM each), 
amino acids and peptide (Cys, Hcy, GHS, 0.2 mM). (d) UV-Vis 
absorption spectra of 1-PAA-UCNPs solutions (1 mg/mL) upon 
addition of different cations (0.1 mM), amino acids and GSH (0.2 
mM). 
 
Figure 4. Bright-field and upconversion luminescence images of 
(a, b) AD brain tissue without treating, (c, d) AD brain tissue pre-
incubation with 100 μM ZnCl2 for 1 hr, (e, f) wild-type tissue 
(W/T), (g, h) AD brain tissue pre-incubation with 5 mM EDTA for 
2 hr, then stained with 1-PAA-UCNPs (500 µg/mL). The scale 
bars is 10 μm. 
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response of UCL signals. In addition, only the addition of 
Zn2+ led to drastic blue shift of the compound 1 absorption 
(Figure 3d), further suggesting the good selectivity of our 
sensor. Therefore, 1-PAA-UCNPs could act as a highly 
selective UCL probe for Zn2+ in vivo without the 
interference from other metals 
Sensing of Zn2+ in Living Cells. To demonstrate the 
potential use of 1-PAA-UCNPs for bioimaging applications, 
the cytotoxicity of both PAA-UCNPs and 1-PAA-UCNPs 
were evaluated on the basis of the reduction activity of 
methyl thiazolyl tetrazolium (MTT) assay. In our study, two 
kinds of cell lines (HeLa: cervical carcinoma and OSCC: oral 
squamous cell carcinoma) were selected. The cell viabilities 
of two cell line are both higher than 95% with the exposure 
of a dose of 600 μg/mL for 24 hr (Figure S11 and S12), 
suggesting that PAA-UCNPs and 1-PAA-UCNPs have 
excellent biocompatibility. To investigate the capability of 
1-PAA-UCNPs for monitoring Zn2+ in cells, the cells were 
incubated with the nanoparticles (500 μg/mL) for 2 hr and 
analyzed under an optical fluorescence microscope 
equipped with a 980 nm laser. Blue UCL emitted by PAA-
UCNPs without assembling of compound 1 can be clearly 
observed from the cells, indicating the cellular uptake of the 
PAA-coated nanoparticles (Figure S13a, b). On the other 
hand, only dim blue UCL can be observed from the cells 
treated with 1-PAA-UCNPs (Figure S13c, d), while the blue 
UCL can be largely recovered by treatment of Zn2+ (0.25 
mM) for 30 min (Figure S13 e, f). By monitoring variation of 
the UCL intensity from the cells in the presence or absence 
of Zn2+, a semi-quantitative detection could be achieved 
(Figure S13 and S14). Taken together, these results confirm 
the feasibility of intracellular Zn2+ monitoring by 1-PAA-
UCNPs. 
The Screening of β-Amyloid in Brain Tissue. AD is 
characterized by the presence of β-amyloid deposits in the 
brain, and oxidative stress has been implicated to play a 
crucial role in the pathogenesis.15 Many recent studies have 
implicated metals to be crucial in the development or 
progression of AD.16 Among these biometals, zinc is 
significant because of its ability to catalyze oxidative 
damage and modulate Alzheimer β-amyloid precursor 
protein processing.17 To further validate the capability of 
our nanoprobes for monitoring Zn2+ ions in biological tissue, 
the triple transgenic knock-in mouse (APPsw/P301L tau/ 
PSENM146) brain with AD was chosen as the model in our 
study owing to the high concentration of Zn2+ ions in the β-
amyloid plaques.18 We next incubated AD brain tissue with 
1-PAA-UCNPs and analyzed using a fluorescence 
microscope. As shown in Figure 4a and b, blue UCL spots 
can be observed from the brain tissue with AD treated by 1-
PAA-UCNPs. We further pre-treated brain slices with Zn2+. 
After incubation with 1-PAA-UCNPs, (Figure 4c and d), we 
surprisingly found that the pre-treatment led to much 
stronger UCL due to the concentrated Zn2+ in β-amyloid. To 
 
Figure 5. Bright-field (a, c, e, g) and upconversion luminescence images (b, d, f, h) of 3-day-old zebrafish incubated with 500 µg/mL 1-
PAA-UCNPs for 2 hr, bright-field (i, k) and upconversion luminescence images (j, l) of zebrafish incubated with EDTA 250 μM for 2 hr 
before 1-PAA-UCNPs (500 µg/mL) incubate for 2 hr, the total length is ∼3 mm. 
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verify that the UCL recovery originated from Zn2+, wild-
type brain tissue (W/T) from normal mouse was employed. 
As shown in Figure 4e and f, very weak UCL could be 
observed from imaging of the W/T tissue with a small 
amount of Zn2+.19 In another set of control experiment, 
EDTA was used to inhibit the coordination between 
compound 1 and Zn2+ owing to its strong chelation property. 
We pre-treated brain tissue with EDTA. As a result, almost 
no emission from brain tissue with 1-PAA-UCNPs could be 
detected (Figure 4g, h), indicating good selectivity of our 
sensor. In addition, the comparison of UCL intensity from 
tissue images reveals that our probes enable the semi-
qualitative detection of Zn2+ in brain tissue (Figure S15). 
Taken together, these results suggest that our designed 
nanoprobes can be promising probes for Zn2+ detection in 
biosamples. 
In Vivo Zn2+ Detection in Zebrafish. Encouraged by the 
results of the in vitro cell imaging and brain tissue studies, 
we further investigated the in vivo detection in living 
animal. In our experiment, zebrafish was chosen as model. 
The transparent zebrafish larva is an ideal animal model to 
monitor analytes using fluorescent sensors due to 
convenient detection of ions by fluorescence microscopy 
and permeability of ions and sensors in its body.20 Therefore, 
zebrafish has been widely used to detect various ions such 
as Cu2+, Ca2+ and Zn2+.21 As a proof of concept experiment, 
we incubated 1-PAA-UCNPs with the living zebrafish and 
then traced the biodistribution of intact Zn2+ inside 
zebrafish by fluorescence microscopic imaging. As shown in 
Figure 5, the bright luminescence of 1-PAA-UCNPs could 
be clearly observed around its ventricle (Figure 5b, d, f and 
h, encircled and arrow pointed). From the zoomed image of 
a part of the head in Figure 5h, it can be found that the 
bright luminescent dots were located at its eyes. We 
attributed it to the high concentration of Zn2+ in this 
position which might be the neuromasts of the anterior 
lateral-line system (ALL system) of zebrafish larva for the 
perception of the water flow.22, 4b As a control experiment, 
3-day-old zebrafish were firstly exposed to EDTA (250 μM 
for 2 hr) before the treatment of 1-PAA-UCNPs (Figure 5j, 
i). The imaging result shows that the obtained UCL signals 
in the fish significantly decreased. Furthermore, by 
quantitative analysis of UCL signals from the zebrafish 
before and after treatment with EDTA (Figure S16), it can 
also be found that the UCL intensity decreased significantly 
after EDTA treatment. All results suggest that the 
fluorescence is resulted from endogenous Zn2+ in zebrafish. 
Therefore, we can conclude that our 1-PAA-UCNPs-based 
sensing system offers an exciting platform for in vivo Zn2+ 
detection. 
■ CONCLUSIONS 
In summary, we have developed a promising sensing 
platform using compound 1-modified upconversion 
nanoprobes for rapid and sensitive detection of Zn2+ in 
aqueous solution. This detection nanosystem exhibited high 
sensitivity down to 0.78 µM and quick response within 5 
seconds. Taking advantage of the good selectivity of 
compound 1 and the intriguing optical properties offered by 
UCNPs, we have also demonstrated our hybrid nanoprobes 
were also applicable for in vitro and in vivo Zn2+ detection 
in the amyloid plaque in AD brain and zebrafish, 
respectively. Our sensing system provides a new 
opportunity for disease diagnosis associated with Zn2+ in 
further clinical medicine. 
■ EXPERIMENTAL SECTION 
Materials. Y(CH3CO2)3•xH2O (99.9%), Yb(CH3CO2)3•4H2O 
(99.9%), Tm(CH3CO2)3•xH2O (99.9%), NaOH (98+%), NH4F 
(98+%), 1-octadecene (90%), oleic acid (OA) (90 %) and 
HCl were purchased from Sigma-Aldrich and used as 
received without further purification. 
Characterization. TEM measurements were carried out 
on a JEL-1400 transmission electron microscope (JEOL) 
operating at an acceleration voltage of 100 kV. UCL spectra 
were obtained with a DM150i monochromator equipped 
with a R928 photon counting photomultiplier tube (PMT), 
in conjunction with a 980 nm diode laser. UV-vis spectra 
were performed using a fluorimeter and UV/Vis instrument, 
SpectraMax M2, Molecular Devices. Cell imaging was 
performed on an Olympus BX51 microscope with a xenon 
lamp adapted to a 980 nm diode laser. The excitation laser 
power was adjusted to 2.5 W, and luminescence 
micrographs were recorded with a Nikon DS-Ri1 color 
imaging system. Image analysis was performed using NIS-
Elements Advanced Research software (Nikon). 
Synthesis of β-NaYF4:Yb/Tm (20/0.2 mol%) Core 
Nanoparticles. In a typical experiment, a water solution (2 
mL) containing Y(CH3CO2)3 (0.32 mmol), Yb(CH3CO2)3 
(0.08 mmol) and Tm(CH3CO2)3 (0.0008 mmol) was added to 
a 50 mL flask containing oleic acid (3 mL) and 1-octadecene 
(7 mL). The resulting mixture was heated to 150 oC for 1.5 
hr to form lanthanide oleate complexes and remove water, 
and then cooled down to 50 oC. Subsequently, a methanol 
solution (6 mL) containing NH4F (1.6 mmol) and NaOH (1 
mmol) was added and stirred at 50 oC for 0.5 hr. The 
temperature of the reaction mixture was heated to 100 oC to 
remove the methanol. Upon removal of the methanol, the 
solution was heated to 290 oC for 1.5 h under an argon flow, 
at which time the mixture was cooled down to room 
temperature. The resulting nanoparticles were precipitated 
out by the addition of ethanol, collected by centrifugation, 
washed with ethanol and cyclohexane, and finally re-
dispersed in cyclohexane. 
Synthesis of NaYF4:Yb/Tm@NaYF4 Core-shell 
Nanoparticles. The core-shell nanoparticles were 
synthesized according to reported procedure.23 To a 50 mL 
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flask containing oleic acid (3 mL) and 1-octadecene (7 mL) 
was added a solution of Y(CH3CO2)3 (0.4 mmol) in water. 
The mixture was then heated to 150 oC for 1.5 hr with 
magnetic stirring and then cooled down to 50 oC. 
NaYF4:Yb/Tm core nanoparticles in cyclohexane were 
added along with a 6 mL methanol solution of NH4F (1.6 
mmol) and NaOH (1 mmol). The resulting mixture was 
stirred at 50 oC for 30 min, at which time the reaction 
temperature was increased to 100 oC to remove the 
methanol. Then the solution was heated to 290 oC under an 
argon flow for 1 hr and cooled to room temperature. The 
resulting nanoparticles were precipitated out by the 
addition of ethanol, collected by centrifugation, washed 
with ethanol and cyclohexane, and re-dispersed in 
cyclohexane. 
Preparation of Hydrophilic NaYF4:Yb/Tm@NaYF4 Core-
Shell Nanoparticles. The preparation of the ligand free 
NaYF4:Yb/Tm@NaYF4 was performed as reported paper.14a 
Firstly, the OA ligands on the surface of 
NaYF4:Yb/Tm@NaYF4 were washed with hydrochloric acid 
and water-dispersible, ligand-free NaYF4:Yb/Tm@NaYF4 
were obtained. Then ligand-free UCNPs were dispersed in 
10 mg/mL PAA solution (adjusted to pH 7 with NaOH), 
followed by stirring for 12 hr, and PAA-UCNPs were 
obtained. Finally, the PAA-UCNPs were washed with 
distilled water by sonication and centrifugation. 
Assembling compound 1 to PAA-UCNPs. 10 mM 
compound 1 in CH2Cl2 (0.2 mL) solution was added 
dropwise into a water solution containing PAA-UCNPs (1 
mg/mL). The solution was then stirred overnight. Free 
compound 1 was removed by centrifugation. The 
precipitate was washed with water by centrifugation. The 
as-obtained hybrid materials (1-PAA-UCNPs) were re-
dispersed by a brief sonication to form a homogeneous 
solution and stored at 4 °C. 
Procedures for Ions Sensing. Stock solutions of the ions 
(2.5 mM) were prepared in H2O. A stock solution of 1-PAA-
UCNPs (1 mg/mL) was prepared in water solution. The 
sensing of 1-PAA-UCNPs to Zn2+ was performed by adding 
different amount of Zn2+ stock solution to 100 μL solution of 
1-PAA-UCNPs, respectively. Test samples for selectivity 
experiments were prepared by adding appropriate amounts 
of ions stock solution with a similar procedure, fluorescent 
spectra of the samples were recorded.  
Movie. Real-time color change of 1-PAA-UCNPs aqueous 
solution upon addition of Zn2+ aqueous solution (3 μL, 100 
mM) was added, and the color was changed from orange to 
yellow within 5 seconds. 
Cell Culture. The cell lines HeLa and OSCC cells were 
grown in DMEM medium supplemented with 10% (v/v) 




antimycotic) in a humidified 
atmosphere at 37oC with 5% (v/v) CO2.  
Cytotoxicity of 1-PAA-UCNPs. To study the cytotoxicity, 
we dispensed 100 μL of cell suspension (~5000 cells/ well) in 
a 96-well plate. The cells were pre-incubated for 24 hr in 
high glucose media (DMEM) with 10 % fetal bovine serum 
(FBS) and 1% Anti-Anti with in a humidified incubator 
(37 °C, 5 %CO2). Next, different concentrations of PAA-
UCNPs, 1-PAA-UCNPs (0, 100, 200, 300, 400, 500, and 600 
μg/mL, diluted in DMEM) were then added to the wells. 
The cells were subsequently incubated for 12 or 24 hr at 
37 °C under 5% CO2. Then, MTT (20 μL, 5 mg/mL) was 
added to each well, and the plate was incubated for an 
additional 4 hr at 37 °C under 5% CO2. After the addition of 
100 μL DMSO, the assay plate was allowed to stand at room 
temperature for 2 hr. The optical density OD570 value (Abs) 
of each well, with background subtraction at 690 nm, was 
measured by means of a fluorimeter and UV/Vis instrument, 
SpectraMax M2, Molecular Devices. The following formula 
was used to calculate the inhibition of cell growth: 
Cell viability(%)=(mean Abs value of treatment 
group/mean Abs value of control)×100% 
Cell Imaging. HeLa and OSCC cell lines were maintained 
at 37 oC in 5% CO2 in DMEM media respectively, both 
supplemented with 10% fetal bovine serum, 100 U/mL 
penicillin and 100 mg/mL streptomycin. The cells were 
plated at around 60-70% confluency 24 hr before imaging 
experiments in 35 mm culture dishes. Prior to imaging 
experiments, the cells were incubated with UCNPs (500 
µg/mL), 1-PAA-UCNPs (500 µg/mL) for 2 hr and the 1-
PAA-UCNPs treated cells incubated with Zn2+ (0.25 mM) 
solution for 30 min. Both cell lines were washed with cell 
culture media and subsequently imaged at ambient 
temperature. 
Biological Sample Preparation. 15-20 months-old triple 
transgenic mice (APPsw/P301L tau/ PSENM146) were 
sacrificed for tissue harvesting. The mice were either 
perfused with 4 % (w/v) paraformaldehyde (PFA), or the 
brain tissue was rapidly frozen and stored at -80 °C 
immediately after extraction. Free-floating sections were 
prepared from the PFA-perfused brain using vibratome 
(Leica) and 40 m slices were stored in anti-freeze solution 
at -20 °C until required. Separately, 10 μm sections of 
rapidly frozen brain were prepared using a cryostat and 
picked up on coated slides and stored in a -20 °C freezer. 
Brain Tissue UCL in Vivo Imaging. Sections were 
mounted on slides, and then treated with 500 μg/mL 1-
PAA-UCNPs at room temperature. Separately, sections 
were pre-treated with 5 mM EDTA or 100 μM Zn2+ 
solutions for 1 hr before staining with 1-PAA-UCNPs. 
Imaging was done with Nikon DS-Ri1 color imaging system. 
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Tracing Distribution of Zn2+ in Zebrafish. Zebrafish were 
kept at 28 °C and maintained at optimal breeding conditions. 
For mating, male and female zebrafish were maintained in 
one tank at 28°C on a 12 hr light/12 hr dark cycle, and then 
the spawning of eggs was triggered by giving light 
stimulation. Zebrafish were maintained in E3 embryo media. 
Zebrafish at 3 day were incubated with 500 μg/mL 1-PAA-
UCNPs for 2 hr at 28°C. Alternatively, 3 day zebrafish were 
exposed to 250 μM EDTA for 2 hr at 28 °C to remove intact 
Zn2+ in zebrafish firstly, then zebrafish were further 
incubated with 1-PAA-UCNPs for 2 hr at 28 °C. The treated 
zebrafish were imaged by an Olympus BX51 microscope 
with a xenon lamp adapted to a 980 nm diode laser. 
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